undamentalytics Newsletter
Sign in

Precision Optics Corporation, Inc. (POCI) stock

Add to watchlist

Add holding +

NASDAQ: POCI Nasdaq Health Care Equipment Next results ~November 12, 2026

C+ Fundamentals grade

Precision Optics Corporation, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in June.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$15

Revenue-to-maturity cash-flow model

Base case. Range ~$12–$18 across our lower- and higher-growth cases (25%–35% a year).

Price vs value

No Buy/Hold/Sell rating is issued: only 2 valuation models apply; a rating needs 3.

Precision Optics Corporation, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders3 buying, 0 selling3 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds20 adding, 9 cuttingOf 5 active managers that changed their stake, 4 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Precision Optics files

Where Precision Optics stands after its latest 10-K

Revenue for the twelve months to June 2026 was $32m, up 65.2% on a year earlier, faster than the 64.2% growth a quarter earlier. That growth ranks 6 of 103 among the health care equipment companies we cover. Free-cash-flow margin rose to -5.8% from -19.0% a year earlier. Operating margin widened to -11.1% from -29.1%. The diluted share count is up 25.6% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 5 of our 7 financial-health checks. Our revenue-to-maturity cash-flow model value is $15.15 a share, against a share price of $4.53.

Source: 10-K filed September 28, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 12, 2026 (estimated)

Precision Optics Corporation, Inc.'s trailing-twelve-month revenue grew 65.2% year on year, with a free-cash-flow margin of -5.8%. Where it stands out: revenue growth of 65.2% ranks 8 of 129 health care equipment companies we cover. Where it lags: gross margin of 17.2% ranks 114 of 123 health care equipment companies we cover.

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 83% in the quarter to 2026-06-30.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 65.2% over the last 12 months, against a median of 9.1% for health care equipment companies we cover.
  • Margins widening. Operating margin is up 18.0 points on a year ago.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Loss-making. Operating margin is -11.1%: costs exceed revenue.
  • Burning cash. Free cash flow was -5.8% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 25.6% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 51% and a beta of 0.4 against the S&P 500.
  • Below peers: gross margin. Gross margin of 17.2% ranks 114 of 123 health care equipment companies we cover (median 61.9%).
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 85.7% over 90 days.

Latest results: FY2026 Q4

Filed September 28, 2026
Earnings per share
-$0.01 against an average estimate of -$0.06: beat by 83.3%
Revenue
$9m, up 42.0% on a year earlier
Share reaction
-7.8% in the first session after the results on September 28, 2026, against -0.9% for the S&P 500
Next report
November 12, 2026; average EPS estimate -$0.13

Precision Optics' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+3.2%
  • 1 week+10.3%
  • 1 month+7.6%
  • This year+14.6%
  • 1 year+11.6%
  • 5 years-27.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$31.5M
Operating margin
-11.1%
Net margin
-11.5%
EPS (TTM, diluted)
$-0.43

Growth

Revenue growth
+65.2%
Change in growth rate
+1.0 pts
Share count change
+25.6%

Cash

Free cash flow (TTM)
-$1.8M
FCF margin
-5.8%
Stock pay % of revenue
3.5%

Earnings

Last results
September 28, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Agreement
  2. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Precision Optics Corporation, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 2 valuation models apply; a rating needs 3.

Valuation models

We value Precision Optics Corporation, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 8.4%: the 10-year Treasury yield (4.9%) plus a beta of 0.78 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$15 ~$12–$18 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$2.8 ~$3.3–$14 Included, half weight
Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$12 ~$2.8–$15 2 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Precision Optics Corporation, Inc. with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20162017201820192020202120222023202420252026
Share price$1.59$1.80$1.59$3.42$4.35$5.04$5.97$6.15$5.90$4.90$5.10
Market value$4m$5m$5m$13m$19m$22m$32m$35m$36m$33m$44m
+ Net debt (− = net cash)−$50059−$118405−$402738−$2m−$1m−$861650$2m−$194900$3m$215016−$8m
Enterprise value$4m$5m$5m$11m$18m$21m$33m$35m$39m$33m$35m
Multiples
Price / sales 1.0x1.6x1.3x1.9x1.9x2.1x2.0x1.7x1.9x1.7x1.4x
Price / earnings ———————————
Price / free cash flow ——54.1x————————
EV / EBITDA ———————————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

34 /100

Weak moat

How hard Precision Optics's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -10.6% of total assets over 10 years.

  • Pricing power 7 / 20

    Gross margin has been a median 31.3%, moving by 6.7 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -10.4%; its worst year was -31.8%.

  • Cash conversion 1 / 20

    Free cash flow was positive in 1 of 10 years, at a median -6.9% of revenue.

  • Discipline 17 / 20

    The diluted share count fell 34.4% over five years; stock-based pay has been a median 4.7% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 12, 2026, after the close. Analysts expect revenue of $6m and EPS of −$0.13 (range −$0.13 to −$0.13) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$0.30 +30% $31m −0%
Next $0.03 +110% $36m +13%

Next year's EPS estimate has moved −85.7% in 90 days, across 1 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +328.6% on 90 days ago. In the last 30 days, 0 analysts raised Precision Optics Corporation, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Precision Optics Corporation, Inc., last 90 days
−$0.40 −$0.20 $0.00 $0.20 $0.40 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.07 Current fiscal year, 60 days ago: −$0.07 Current fiscal year, 30 days ago: −$0.07 Current fiscal year, 7 days ago: −$0.07 Current fiscal year, Now: −$0.30 −$0.30 Next fiscal year, 90 days ago: $0.21 Next fiscal year, 60 days ago: $0.21 Next fiscal year, 30 days ago: $0.21 Next fiscal year, 7 days ago: $0.21 Next fiscal year, Now: $0.03 $0.03

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.07$0.21
60 days ago −$0.07$0.21
30 days ago −$0.07$0.21
7 days ago −$0.07$0.21
Now −$0.30$0.03

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.06 −$0.01 +83.3%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

1 analysts, Oct 2026
Buy1100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202611

Counts of recommendations published by analysts covering Precision Optics Corporation, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
0.0%
of tradable shares
Days to cover
0.06
at average volume
Short interest, 1 month
−44%
to October 15, 2026
Held by institutions
42%
of shares
Held by insiders
19.6%
of shares
Employees
108
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +11.6%

$4.30 on October 31, 2025 to $4.80

ThenNowEffect
Revenue (last 12 months) $19m $32m +65.2%
P/S multiple 1.5x 1.3x −15.1%
Share count 7m 9m −20.4%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
POCI+60%−23%+8%−20%−13%+15%
Industry peers (median)−9%−37%−9%−19%−16%−15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
POCI75%33%58%58%42%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
POCI−25%−37%−24%−45%−24%−34%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 3, 2015: 62% from December 8, 2015 to January 13, 2016. Getting back needed a 166% gain, reached on August 16, 2018, 946 days after the low.

Price behaviour

52-week range
$3.90 – $5.96
From 52-week high
−19.5%
vs 50-day average
+8.5%
vs 200-day average
+3.8%
Volatility (1 year)
51%
Beta vs S&P 500
0.36

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
1 up, 4 down
typical move ±7.2%
After a week
1 up, 4 down
typical move ±9.8%
After a month
1 up, 4 down
typical move ±25.0%
Results releasedNext dayS&P 500 next day5 days21 days
September 28, 2026 −7.8% −0.9% −3.7% −4.8%
October 1, 2024 −10.4% −0.9% −19.4% −32.4%
August 14, 2024 −10.1% +2.0% −10.3% −7.5%
October 20, 2022 +1.0% +1.6% +2.1% −0.3%
August 8, 2018 −6.7% −0.2% −13.3% +80.0%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Precision Optics Corporation, Inc. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Precision Optics Corporation, Inc.
$15M $20M $25M $30M $35M FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 Revenue (TTM), FY24 Q1: $20.3M Revenue (TTM), FY24 Q2: $19.2M Revenue (TTM), FY24 Q3: $19.4M Revenue (TTM), FY24 Q4: $19.1M Revenue (TTM), FY25 Q1: $19M Revenue (TTM), FY25 Q2: $18.7M Revenue (TTM), FY25 Q3: $17.6M Revenue (TTM), FY25 Q4: $19.1M Revenue (TTM), FY26 Q1: $21.6M Revenue (TTM), FY26 Q2: $24.4M Revenue (TTM), FY26 Q3: $28.9M Revenue (TTM), FY26 Q4: $31.5M $31.5M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY24 Q1 $20.3M
FY24 Q2 $19.2M
FY24 Q3 $19.4M
FY24 Q4 $19.1M
FY25 Q1 $19M
FY25 Q2 $18.7M
FY25 Q3 $17.6M
FY25 Q4 $19.1M
FY26 Q1 $21.6M
FY26 Q2 $24.4M
FY26 Q3 $28.9M
FY26 Q4 $31.5M
Revenue growth, TTM YoY Precision Optics Corporation, Inc.
-20% 0% 20% 40% 60% 80% FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 Revenue growth, TTM YoY, FY24 Q1: 10.1% Revenue growth, TTM YoY, FY24 Q2: -5.9% Revenue growth, TTM YoY, FY24 Q3: -6.7% Revenue growth, TTM YoY, FY24 Q4: -9.2% Revenue growth, TTM YoY, FY25 Q1: -6.4% Revenue growth, TTM YoY, FY25 Q2: -2.8% Revenue growth, TTM YoY, FY25 Q3: -9.2% Revenue growth, TTM YoY, FY25 Q4: -0.1% Revenue growth, TTM YoY, FY26 Q1: 13.7% Revenue growth, TTM YoY, FY26 Q2: 30.7% Revenue growth, TTM YoY, FY26 Q3: 64.2% Revenue growth, TTM YoY, FY26 Q4: 65.2% 65.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY24 Q1 10.1%
FY24 Q2 -5.9%
FY24 Q3 -6.7%
FY24 Q4 -9.2%
FY25 Q1 -6.4%
FY25 Q2 -2.8%
FY25 Q3 -9.2%
FY25 Q4 -0.1%
FY26 Q1 13.7%
FY26 Q2 30.7%
FY26 Q3 64.2%
FY26 Q4 65.2%
Operating margin (TTM) Precision Optics Corporation, Inc.
-40% -30% -20% -10% 0% FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 Operating margin (TTM), FY24 Q1: -4.6% Operating margin (TTM), FY24 Q2: -11.5% Operating margin (TTM), FY24 Q3: -10.2% Operating margin (TTM), FY24 Q4: -14.3% Operating margin (TTM), FY25 Q1: -18.8% Operating margin (TTM), FY25 Q2: -20.2% Operating margin (TTM), FY25 Q3: -31.5% Operating margin (TTM), FY25 Q4: -29.1% Operating margin (TTM), FY26 Q1: -27.3% Operating margin (TTM), FY26 Q2: -27.6% Operating margin (TTM), FY26 Q3: -16.4% Operating margin (TTM), FY26 Q4: -11.1% -11.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q1 -4.6%
FY24 Q2 -11.5%
FY24 Q3 -10.2%
FY24 Q4 -14.3%
FY25 Q1 -18.8%
FY25 Q2 -20.2%
FY25 Q3 -31.5%
FY25 Q4 -29.1%
FY26 Q1 -27.3%
FY26 Q2 -27.6%
FY26 Q3 -16.4%
FY26 Q4 -11.1%
FCF margin (TTM) Precision Optics Corporation, Inc.
-30% -20% -10% 0% FY24 Q1 FY24 Q4 FY25 Q3 FY26 Q4 FCF margin (TTM), FY24 Q1: -8.3% FCF margin (TTM), FY24 Q2: -9.1% FCF margin (TTM), FY24 Q3: -13.2% FCF margin (TTM), FY24 Q4: -15.5% FCF margin (TTM), FY25 Q1: -10.0% FCF margin (TTM), FY25 Q2: -13.2% FCF margin (TTM), FY25 Q3: -23.5% FCF margin (TTM), FY25 Q4: -19.0% FCF margin (TTM), FY26 Q1: -15.0% FCF margin (TTM), FY26 Q2: -11.2% FCF margin (TTM), FY26 Q3: -5.5% FCF margin (TTM), FY26 Q4: -5.8% -5.8%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY24 Q1 -8.3%
FY24 Q2 -9.1%
FY24 Q3 -13.2%
FY24 Q4 -15.5%
FY25 Q1 -10.0%
FY25 Q2 -13.2%
FY25 Q3 -23.5%
FY25 Q4 -19.0%
FY26 Q1 -15.0%
FY26 Q2 -11.2%
FY26 Q3 -5.5%
FY26 Q4 -5.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2011 Jun 2011 2012 Jun 2012 2013 Jun 2013 2014 Jun 2014 2015 Jun 2015 2016 Jun 2016 2017 Jun 2017 2018 Jun 2018 2019 Jun 2019 2020 Jun 2020 2021 Jun 2021 2022 Jun 2022 2023 Jun 2023 2024 Jun 2024 2025 Jun 2025 2026 Jun 2026
Income
Revenue 2 2 3 4 4 4 3 4 7 10 11 16 21 19 19 32
Gross profit 1 1 1 1 1 1 1 1 2 3 3 5 8 6 3 5
EBITDA −1 −1 −1 −1 −1 −1 −1 −0 −1 −1 −1 −1 −0 −3 −5 −3
Operating income −1 −1 −1 −1 −1 −1 −1 −0 −1 −1 −1 −2 −1 −3 −6 −4
Net income −1 1 −2 −1 −1 −1 −1 −0 −1 −1 −0 −1 −0 −3 −6 −4
Diluted EPS −$1.06 $2.34 −$0.51 −$0.26 −$0.19 −$0.15 −$0.12 −$0.04 −$0.05 −$0.11 −$0.01 −$0.18 −$0.03 −$0.49 −$0.85 −$0.43
Growth (year on year)
Revenue — −4.1% +17.1% +44.9% +7.1% +0.1% −19.5% +28.0% +68.5% +45.8% +7.6% +46.9% +34.2% −9.2% −0.1% +65.2%
Net income — — −286.0% — — — — — — — — — — — — —
Diluted EPS — — −121.8% — — — — — — — — — — — — —
Margins
Gross margin 33.5% 25.9% 26.0% 21.9% 20.4% 24.1% 24.5% 36.7% 31.2% 33.9% 32.2% 31.4% 36.8% 30.3% 17.8% 17.2%
EBITDA margin −41.6% −58.6% −48.1% −31.2% −30.5% −26.3% −30.7% −8.0% −8.4% −13.2% −7.1% −8.4% −2.0% −13.1% −28.0% −10.2%
Operating margin −44.2% −59.7% −48.9% −31.8% −31.0% −26.9% −31.8% −8.6% −9.0% −14.3% −8.5% −9.7% −3.0% −14.3% −29.1% −11.1%
Net margin −46.9% 44.6% −70.9% −31.8% −30.1% −26.4% −31.9% −8.7% −9.0% −14.4% −1.0% −5.9% −0.7% −15.4% −30.3% −11.5%
Free-cash-flow margin — −73.7% −51.8% −24.3% −21.4% −22.5% −22.0% 2.4% −17.2% −7.2% −0.3% −6.7% −0.5% −15.5% −19.0% −6.3%
Cash flow
Cash from operations −0 −2 −1 −1 −1 −1 −1 0 −1 −1 0 −1 −0 −3 −3 −2
Capital spending — 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Free cash flow — −2 −1 −1 −1 −1 −1 0 −1 −1 −0 −1 −0 −3 −4 −2
Stock-based pay 0 0 0 0 0 0 0 0 0 1 1 1 1 1 2 1
Free cash flow after stock pay — −2 −1 −1 −1 −1 −1 0 −1 −1 −1 −2 −1 −4 −5 −3
Balance sheet
Cash 0 0 1 0 0 0 0 0 2 1 1 1 3 0 2 10
Total debt 1 0 0 0 0 0 0 0 0 0 0 2 3 3 2 2
Net debt (negative = net cash) 1 −0 −1 −0 −0 −0 −0 −0 −2 −1 −1 2 −0 3 0 −8
Diluted shares — — 1m 1m 2m 2m 3m 3m 4m 4m 4m 5m 6m 6m 7m 9m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

5 of 7 checks passed · June 30, 2026
What it owns · $32m
Short-term assets $20mLonger-term assets $12m
What it owes, and who funded it · $32m
Short-term liabilities $9mLonger-term liabilities $3mShareholders' equity $20m
  • Short-term assets cover short-term liabilities $20m of assets due within a year against $9m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $20m short-term assets against $3m of longer-dated liabilities.
  • More cash than debt $10m of cash against $1m of debt.
  • Debt below 40% of shareholders' equity Debt is 6% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 23% to 6% over five years.
  • A year's operating cash flow covers at least 20% of debt −$2m of operating cash flow against $1m of debt.
  • Operating profit covers interest at least five times over Operating income of −$4m against $148,129 of interest.

From Precision Optics Corporation, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+25.6%
year over year
R&D spending
3.3%
of revenue
Sales & admin spending
25.1%
of revenue
Days sales outstanding
69 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care equipment
Last 12 months unless stated POCI OBIO STXS RVP UTMD ECOR Median
Revenue, last 12 months $32m $32m $30m $34m $36m $37m $99m
Revenue growth, last 12 months 65.2% 986.1% −5.5% −11.2% −7.0% 33.5% 9.2%
Revenue growth, 3-year average 14.4% 94.5% 0.8% −14.7% −11.4% 50.4% 13.5%
Revenue growth, latest quarter 42.0% −89.5% −12.8% −31.1% −14.3% 28.0% 10.2%
Gross margin 17.2% 99.5% 55.6% −1.4% 57.9% 87.1% 61.2%
Operating margin −11.1% −181.4% −75.7% −66.9% 28.4% −37.6% −8.5%
Operating margin, 3-year average −18.2% <−999% −80.7% −52.5% 31.2% −51.0% −17.9%
Net margin −11.5% −184.6% −74.2% −9.9% 29.0% −40.0% −12.0%
Cash from operations / revenue −4.9% −182.4% −50.9% −14.6% 32.8% −26.3% −1.9%
Free-cash-flow margin −5.8% −184.8% −51.6% −37.7% 31.7% −26.4% −3.9%
Free-cash-flow margin, 3-year average −13.4% <−999% −37.3% −20.6% 35.4% <−999% −7.0%
Stock pay / revenue 3.5% 34.8% 28.8% 10.7% 1.1% 7.2% 6.1%
Change in share count 25.6% 58.1% 11.1% 0.0% −4.8% 8.5% 4.0%

Median of all 134 companies we cover in health care equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

134 health care equipment companies
Measure Company Peer median Rank
Revenue growth Growth 65.2% 9.1% 8 of 129
Change in growth rate Growth +1.0pp -0.6pp 42 of 129
Gross margin Profitability 17.2% 61.9% 114 of 123
Operating margin Profitability -11.1% -8.3% 70 of 132
Net margin Profitability -11.5% -12.0% 66 of 133
Free-cash-flow margin Cash generation -5.8% -3.4% 68 of 128
Stock pay as % of revenue Cash generation 3.5% 6.1% 45 of 123
Long-term debt as % of assets Balance sheet 2.2% 24.2% 16 of 87
Change in share count Balance sheet 25.6% 3.3% 95 of 115
Days sales outstanding Balance sheet 69 days 57 days 81 of 118

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to June 30, 2026
Products and services
Line of business Revenue Share YoY
Systems Manufacturing $22.6M 71.8% ▲ 172.9%
Ross Optical Industries $4.9M 15.6% ▲ 31.7%
Engineering Design Services $3.5M 11.0% ▼ 29.7%
Micro Optics Lab $519,540 1.6% ▼ 75.7%

From Precision Optics Corporation, Inc.'s 10-K filed September 28, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$20.1M
Institutions reporting
31
Shares held vs prior quarter
▲ 1.7%
Positions opened / closed
9 / 4

Top buyers and sellers, Q2 2026: 20 institutions bought and 9 sold ; the biggest buyer was Nantahala Capital Management, LLC (+280K shares) and the biggest seller Bleichroeder LP (−271K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Needham Investment Management LLC $8.5M 1.7M 42.4% 0.0%
Nantahala Capital Management, LLC $2.9M 560K 14.2% ▲ 100.0%
Myda Advisors LLC $1.9M 375K 9.5% ▼ 6.2%
Vanguard Capital Management LLC $1.7M 326K 8.3% ▲ 67.8%
Wealthtrust Axiom LLC $1.3M 260K 6.6% ▲ 2.5%
Morgan Stanley $916,439 180K 4.6% ▲ 25.0%
Hightower Advisors, LLC $634,149 124K 3.2% ▲ 28.8%
Geode Capital Management, LLC $337,364 66K 1.7% ▲ 0.2%
Renaissance Technologies LLC $275,910 54K 1.4% New
Essex Investment Management Co LLC $237,813 47K 1.2% New
Stonepine Capital Management, LLC $236,589 46K 1.2% ▼ 53.6%
Citadel Advisors LLC $212,849 42K 1.1% ▲ 79.6%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Precision Optics Corporation, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $229,993 3 trades by 3 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $229,993 net buying
Insider Date Trade Shares Price Value
Forkey Joseph Norman Chief Executive Officer March 30, 2026 Buy 1,388 $3.60 $4,997
Traut Joseph Chief Operating Officer March 30, 2026 Buy 41,666 $3.60 $149,998
Coll Wayne M Chief Financial Officer March 30, 2026 Buy 20,833 $3.60 $74,999

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

  • September 28, 2026
  • October 1, 2024
  • August 14, 2024
  • October 20, 2022
  • August 8, 2018
  • November 27, 2007

Recent SEC filings

Data status

When each part of this page on Precision Optics Corporation, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Precision Optics Corporation, Inc. in brief

What does Precision Optics Corporation, Inc. do?
Precision Optics Corporation, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in June.
What is Precision Optics Corporation, Inc.'s stock ticker?
Precision Optics Corporation, Inc. trades under the ticker POCI on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Precision Optics Corporation, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Precision Optics Corporation, Inc. reported revenue of $31.5M, 65.2% higher than a year earlier, according to its SEC filings.
What is Precision Optics Corporation, Inc.'s free cash flow?
Precision Optics Corporation, Inc.'s free-cash-flow margin is -5.8% of revenue over the trailing twelve months, ranking 68 of the 128 health care equipment companies we cover.
Who are Precision Optics Corporation, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Needham Investment Management LLC, Nantahala Capital Management, LLC and Myda Advisors LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Precision Optics Corporation, Inc.'s market cap?
On June 30, 2026, Precision Optics Corporation, Inc.'s market capitalisation was about $43.5M and net debt of -$8.3M. Market figures come from third-party market data and may be delayed.
How much debt does Precision Optics Corporation, Inc. have?
Precision Optics Corporation, Inc.'s debt-to-equity ratio is 6.3%, from its latest balance sheet (23.3% five years earlier). The financial health section below sets out its other solvency checks.
Who are Precision Optics Corporation, Inc.'s competitors?
In our Health Care Equipment peer group, the companies closest to Precision Optics Corporation, Inc. are Orchestra Biomed Holdings, Inc., Stereotaxis, Inc., Retractable Technologies Inc, Utah Medical Products Inc and Electrocore, Inc. The side-by-side comparison below sets their revenue, margins and growth against Precision Optics Corporation, Inc.'s.
Are insiders buying or selling Precision Optics Corporation, Inc. stock?
Over the last 12 months, Precision Optics Corporation, Inc.'s directors and officers reported 3 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Precision Optics Corporation, Inc.'s next earnings date?
Around November 12, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Precision Optics Corporation, Inc. announces its own schedule.